pembrolizumab
Drug / Medication
A checkpoint inhibitor used in immunotherapy, particularly effective in triple-negative breast cancers.
Mentioned in 3 videos
Save the 3 videos on pembrolizumab to your own pod.
Sign up free to keep building your knowledge base on pembrolizumab as more episodes are added.
Videos Mentioning pembrolizumab
#133 - Vinay Prasad, M.D., M.P.H: Hallmarks of successful cancer policy
Peter Attia MD
A checkpoint inhibitor that shows clear survival benefits in specific oncology settings, but has also been disappointing in others, making its effectiveness case-by-case.
278 ‒ Breast cancer: how to catch, treat, and survive breast cancer | Harold Burstein, M.D., Ph.D.
Peter Attia MD
A checkpoint inhibitor used in immunotherapy, particularly effective in triple-negative breast cancers.
Journal Club with Dr. Peter Attia | Effects of Light & Dark on Mental Health & Treatments for Cancer
Andrew Huberman
An anti-PD-1 drug that emerged after Ipilimumab, showing greater response rates and overall survival in metastatic melanoma, famously used to cure a friend's pancreatic cancer.